Profil
Ailsa Helen Louise Craig is currently a Portfolio Manager at International Biotechnology Trust Plc and a Fund Manager at Schroder Investment Management Ltd. Formerly, the roles include Investment Manager at SV Health Investors LLP, Investment Analyst at Baring Asset Management Ltd. from 2004 to 2006, and Investment Manager at SV Health Managers LLP from 2008 to 2023.
Education includes an undergraduate degree from The University of Manchester.
Postes actifs de Ailsa Helen Louise Craig
| Sociétés | Poste | Début |
|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | Corporate Officer/Principal | - |
Schroder Investment Management Ltd.
Schroder Investment Management Ltd. Investment ManagersFinance SIM is an active investment manager that utilizes a contrarian investment approach supported by fundamental, in-house research, regular company visits and their group's global network. Research is shared worldwide within the parent group and is organized in specialist teams, with local specialists contributing their expertise to global sector teams. The firm also utilizes their proprietary software, the Global Research Investment Database, to integrate and distribute in-house and external research, assisting investment managers in portfolio construction. They manage risk through another proprietary tool called Portfolio Risk Investment Strategy Manager (PRISM). | Gestionnaire de Portefeuille-Actions | 01/11/2023 |
Anciens postes connus de Ailsa Helen Louise Craig
| Sociétés | Poste | Fin |
|---|---|---|
SV Health Managers LLP
SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Analyst-Equity | 01/01/2008 |
Baring Asset Management Ltd.
Baring Asset Management Ltd. Investment ManagersFinance Barings UK focuses on building long-term, trusted partnerships with their clients and utilizes an active management approach, built upon fundamental analysis, to help meet their long-term investment goals. The firm leverages its depth and breadth of expertise across the global fixed income, alternative investment and equity markets. Their expansive asset market coverage, includes global fixed income presence and high active equity expertise in international and emerging markets, contributes to the firm’s strength in multi-asset investing. This encompasses solutions such as income, target return and absolute return. | Analyst-Equity | 01/01/2006 |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Analyste en capital-investissement | - |
Formation de Ailsa Helen Louise Craig
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
International Biotechnology Trust Plc
International Biotechnology Trust Plc Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Schroder Investment Management Ltd.
Schroder Investment Management Ltd. Investment ManagersFinance SIM is an active investment manager that utilizes a contrarian investment approach supported by fundamental, in-house research, regular company visits and their group's global network. Research is shared worldwide within the parent group and is organized in specialist teams, with local specialists contributing their expertise to global sector teams. The firm also utilizes their proprietary software, the Global Research Investment Database, to integrate and distribute in-house and external research, assisting investment managers in portfolio construction. They manage risk through another proprietary tool called Portfolio Risk Investment Strategy Manager (PRISM). | Finance |
SV Health Investors LLP
SV Health Investors LLP Investment ManagersFinance SV Health Investors invests in companies located across the Globe. The firm focuses on biotechnology, pharmaceuticals, medical devices & instruments and healthcare services sectors. It provides financing for seed, early, growth stage and buyout capital requirements. | Finance |
Baring Asset Management Ltd.
Baring Asset Management Ltd. Investment ManagersFinance Barings UK focuses on building long-term, trusted partnerships with their clients and utilizes an active management approach, built upon fundamental analysis, to help meet their long-term investment goals. The firm leverages its depth and breadth of expertise across the global fixed income, alternative investment and equity markets. Their expansive asset market coverage, includes global fixed income presence and high active equity expertise in international and emerging markets, contributes to the firm’s strength in multi-asset investing. This encompasses solutions such as income, target return and absolute return. | Finance |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SV Health Managers LLP
SV Health Managers LLP Investment ManagersFinance SVHM is a hands-on manager which focuses investments in the human life sciences sector (biotechnology/biopharmaceuticals, medical devices, healthcare services and healthcare information technology). Their geographic focus is on North America and Western Europe, but they consider investment opportunities in other regions where there is a well-developed life sciences sector. SVHM's invests in companies with a very high quality management team and a business model that could provide a strong increase in value, often with a key technology protectable by law. They may occupy a strong, preferably proprietary position in a large or niche market or may have an early position in a fast growing market. | Finance |
















